| Literature DB >> 23766853 |
Tatiana Barichello1, Jaqueline S Generoso, Lutiana R Simões, Samuel G Elias, João Quevedo.
Abstract
Pneumococcal meningitis is a life-threatening disease characterized by an acute purulent infection affecting the pia mater, the arachnoid, and the subarachnoid spaces. Streptococcus pneumoniae crosses the blood-brain barrier (BBB) by both transcellular traversal and disruption of the intraepithelial tight junctions to allow intercellular traversal. During multiplication, pneumococci release their bacterial products, which are highly immunogenic and may lead to an increased inflammatory response in the host. Thus, these compounds are recognized by antigen-presenting cells through the binding of toll-like receptors. These receptors induce the activation of myeloid differentiation factor 88 (MyD88), which interacts with various protein kinases, including IL-1 receptor-associated kinase-4 (IRAK4), which is phosphorylated and dissociated from MyD88. These products also interact with tumor necrosis factor receptor-associated factor 6 dependent signaling pathway (TRAF6). This cascade provides a link to NF- κ B-inducing kinase, resulting in the nuclear translocation of NF- κ B leading to the production of cytokines, chemokines, and other proinflammatory molecules in response to bacterial stimuli. Consequently, polymorphonuclear cells are attracted from the bloodstream and then activated, releasing large amounts of NO(•), O2(•), and H2O2. This formation generates oxidative and nitrosative stress, subsequently, lipid peroxidation, mitochondrial damage, and BBB breakdown, which contributes to cell injury during pneumococcal meningitis.Entities:
Mesh:
Year: 2013 PMID: 23766853 PMCID: PMC3665263 DOI: 10.1155/2013/371465
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Mechanisms of microbial traversal of the BBB. S. pneumoniae crosses the BBB through transcellular traversal and paracellular traversal.
Figure 2Innate immune system in pneumococcal meningitis infection. The majority of TLRs utilize a common intracellular adapter protein known as myeloid differentiation factor 88 (MyD88): it activates IRAK, which is phosphorylated and dissociated from MyD88. Thus, it interacts with the tumor necrosis factor receptor-associated factor 6 dependent signaling pathway (TRAF6). TRAF6 stimulates to the transforming growth factor β-activated kinase (TAK1). TAK1 activates the IKK (Inhibitor of IκB kinase), resulting in the destruction of IkB and subsequently, NF-κB activation resulting in the nuclear translocation of NF-κB. This cascade provides a link to NF-κB-inducing kinase, resulting in the nuclear translocation of NF-κB, which induces the production of cytokines, chemokines, and others proinflammatory molecules in response to bacterial stimuli.
Figure 3Leukocyte migration. Leukocytes leave the blood and migrate to sites of infection. Sialyl-LewisX on leukocytes binds to selectins P and E on endothelial cells. This binding becomes stronger when CXCL-8 binds to its specific receptor on neutrophils, triggering the production of integrin LFA-1 and CX3 (mac-1). Inflammatory cytokines, such as TNF-α, are also necessary to induce expression of the adhesion molecules ICAM-1 and ICAM-2. The interaction between endothelial cells and ICAM-1 allows the passage of neutrophils along a gradient of chemoattractants substances.